Researchers are also looking at other drugs to help slow or stop the growth of carcinoid tumors. "There are a few drugs currently going through clinical trials or awaiting FDA approval," says ...

After being misdiagnosed with irritable bowel syndrome, Christina took to searching online, which consistently returned terms like “neuroendocrine cancer” and “carcinoid syndrome.” ...

WE recently recognized distinctive ophthalmic consequences of the carcinoid syndrome that have not been reported. Patients with malignant carcinoid were studied during their hospital courses at ...

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) a clinical stage pharmaceutical company focused on the discovery, development and commercialization of ...

In this study, we examined the genetic profile of appendiceal carcinomas including 11 goblet cell carcinoids, 7 adenocarcinomas ex-goblet cell carcinoid, and 7 primary colorectal-type ...

SAN DIEGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced positive initial findings from its ongoing open-label Phase 2 carcinoid syndrome (CS ...

He subsequently developed dyspnea on exertion. Diagnosis. Carcinoid tumor of midgut origin with large segment 3 liver metastasis. Carcinoid syndrome and carcinoid heart disease. Management.

(Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc's oral drug to treat carcinoid syndrome diarrhea, a condition that develops in ...

(RTTNews) - Amryt (AMYT) on Thursday said the Food and Drug Administration has granted Orphan Drug Designation to its Mycapssa for the treatment of carcinoid syndrome. Carcinoid syndrome is a set ...

Cedars-Sinai is the only facility in the western U.S. offering this clinical trial. Patients with carcinoid cancer require highly specialized medical care to both diagnose and individually treat ...